Stock Events

Stock Events

Sernova Biotherapeutics 

€0.11
0
-€0-3.6% Today

Statistics

Day High
0.11
Day Low
0.11
52W High
0.15
52W Low
0.08
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12JunExpected
Q4 2025
Next
-0.01
-0.01
-0.01
-0.01
Expected EPS
-0.00614064465
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PSH0.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vericel
VCEL
Mkt Cap1.72B
Vericel Corporation specializes in cell therapies for markets similar to Sernova's, making them direct competitors in the regenerative medicine space.
Biolife Solutions
BLFS
Mkt Cap953.44M
BioLife Solutions provides bioproduction tools and services, including cell and gene therapy solutions, competing in the same support and supply chain as Sernova.
Mesoblast
MESO
Mkt Cap1.96B
Mesoblast Limited focuses on regenerative medicine, specifically in areas of inflammation and cardiovascular disease, overlapping with Sernova's therapeutic targets.
Brainstorm Cell Therapeutics
BCLI
Mkt Cap10.15M
Brainstorm Cell Therapeutics develops adult stem cell therapies for neurodegenerative diseases, competing with Sernova's approach to chronic disease treatment through innovative therapies.
CRISPR Therapeutics
CRSP
Mkt Cap4.92B
CRISPR Therapeutics is focused on gene editing, a cutting-edge area of medicine that competes indirectly with Sernova's cell therapy and regenerative medicine technologies.
Editas Medicine
EDIT
Mkt Cap287.74M
Editas Medicine operates in the gene editing space, which represents a competitive alternative to Sernova's cell-based therapies for treating various diseases.
Intellia Therapeutics
NTLA
Mkt Cap1.59B
Intellia Therapeutics is another key player in the gene editing field, offering therapeutic solutions that could potentially rival Sernova's cell therapy approach.
Sangamo Therapeutics
SGMO
Mkt Cap104.07M
Sangamo Therapeutics focuses on genomic medicine, including gene therapy, gene editing, and cell therapy, directly competing with Sernova's technology in multiple areas.

About

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.
Show more...
CEO
Mr. Jonathan M. N. Rigby M.B.A.
Employees
8
Country
Canada
ISIN
CA81752F1062

Listings

XETRA
DE
PSH0.XETRA
F
DE
PSH0.F
STU
DE
PSH0.STU
MU
DE
PSH0.MU

0 Comments

Share your thoughts

FAQ

What is Sernova Biotherapeutics stock price today?▼
The current price of PSH0.MU is €0.11 EUR — it has decreased by -3.6% in the past 24 hours. Watch Sernova Biotherapeutics stock price performance more closely on the chart.
What is Sernova Biotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sernova Biotherapeutics stocks are traded under the ticker PSH0.MU.
Is Sernova Biotherapeutics stock price growing?▼
PSH0.MU stock has risen by +5.42% compared to the previous week, the month change is a -0.93% fall, over the last year Sernova Biotherapeutics has showed a -5.31% decrease.
When is the next Sernova Biotherapeutics earnings date?▼
Sernova Biotherapeutics is going to release the next earnings report on June 12, 2026.
What were Sernova Biotherapeutics earnings last quarter?▼
PSH0.MU earnings for the last quarter are -0.01 EUR per share, whereas the estimation was -0.01 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Sernova Biotherapeutics have?▼
As of April 15, 2026, the company has 8 employees.
In which sector is Sernova Biotherapeutics located?▼
Sernova Biotherapeutics operates in the Other sector.
When did Sernova Biotherapeutics complete a stock split?▼
Sernova Biotherapeutics has not had any recent stock splits.
Where is Sernova Biotherapeutics headquartered?▼
Sernova Biotherapeutics is headquartered in Mississauga, Canada.